Předmět: |
|
Zdroj: |
Blood Weekly; 11/14/2024, p493-493, 1p |
Abstrakt: |
A recent study from Yozgat Bozok University explores the potential of JWH-133 in inhibiting the TLR4/NF-kB signaling pathway in uterine ischemia-reperfusion injury. The study conducted on female Wistar albino rats showed that JWH-133 significantly reduced the expression levels of inflammatory markers associated with reperfusion injury. The research suggests that JWH-133 could be a promising therapeutic target for inflammation in ischemia-reperfusion injury, paving the way for future investigations in this area. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|